Aberrant Receptor-Mediated Cushing’s Syndrome

Publisher： Karger

E-ISSN： 1663-2826|59|1|99-103

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.59, Iss.1, 2004-11, pp. : 99-103

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Coagulopathy in Cushing’s Syndrome

By  

Neuroendocrinology, Vol. 92, Iss. 1, 2010-09 ,pp. : 55-59

Karger

Access to resources Recommend Favorite

Genetics of Cushing’s Syndrome

By  

Neuroendocrinology, Vol. 92, Iss. 1, 2010-09 ,pp. : 6-10

Karger

Access to resources Recommend Favorite

Epidemiology of Cushing’s Syndrome

By  

Neuroendocrinology, Vol. 92, Iss. 1, 2010-09 ,pp. : 1-5

Karger

Access to resources Recommend Favorite

Medical Treatment of Cushing’s Syndrome: Glucocorticoid Receptor Antagonists and Mifepristone

By  

Neuroendocrinology, Vol. 92, Iss. 1, 2010-09 ,pp. : 125-130

Karger

Access to resources Recommend Favorite

Metabolic Syndrome in Cushing’s Syndrome

By  

Neuroendocrinology, Vol. 92, Iss. 1, 2010-09 ,pp. : 96-101

Karger

Access to resources Recommend Favorite